<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04381702</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL19_0253</org_study_id>
    <nct_id>NCT04381702</nct_id>
  </id_info>
  <brief_title>Outcome After Laparoscopic Versus Open Pancreaticoduodenectomy</brief_title>
  <acronym>PaMIvOP</acronym>
  <official_title>Outcome After Laparoscopic Versus Open Pancreaticoduodenectomy: a Single Surgeon Experience</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Department of Digestive Surgery and Transplantation, Université de Montpellier- Nîmes, Montpellier, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Department of Medical Oncology, Université de Montpellier- Nîmes, Montpellier, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Department of Anesthesia and Critical Care, Université de Montpellier- Nîmes, Montpellier, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study :

      To determine the morbimortality of Laparoscopic pancreaticoduodenectomy (LPD) compared to the
      gold standard Open pancreaticoduodenectomy approach (OPD).

      Methods :

      This is a monocentric retrospective study based on a prospectively maintained clinical
      database. The study included 28 consecutive patients operated, between January 2016 and March
      2019, of Laparoscopic pancreaticoduodenectomy (LPD) that we compared to 62 patients operated
      with the classical open approach by the same surgeon before the first laparoscopic resection
      at our institution.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The progress achieved over the last 20 years and the growing experience of visceral surgeons
      in minimally invasive surgery allow us today to embark on increasingly complex surgeries.

      Laparoscopic surgery has even become the gold standard approach for many interventions,
      whether for bariatric functional surgery, reflux surgery, pelvic static disorder surgery, but
      also for tumor surgery such as colorectal cancer, esophageal or tail of the pancreas.

      However, there are still interventions which, due to their technical difficulty, do not find
      unanimous consensus among the international scientific community for a possible minimally
      invasive approach.

      The close contact of the pancreatic gland with the splenomesaraic trunk making laparoscopic
      dissection difficult with risk of uncontrollable bleeding.

      It seems, however, that the finesse of the dissection and coagulation instruments and the
      precision of today's optics make it possible to approach the head of the pancreas in
      completely satisfactory conditions.

      Several centers around the world have developed the LPD technique with encouraging results in
      terms of perioperative mortality without showing any advantage over laparotomy.

      At the Montpellier University Hospital we started performing Laparoscopic
      pancreaticoduodenectomy (LPD) at the beginning of 2016.

      The aim of this study is to assess, on the one hand, the morbimortality and the quality of
      surgery linked to the development of this relatively new technique in a reference center for
      pancreatic surgery and on the other hand to assess a possible learning curve effect within
      our experience.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2016</start_date>
  <completion_date type="Actual">October 1, 2019</completion_date>
  <primary_completion_date type="Actual">September 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Morbimortality of Laparoscopic pancreaticoduodenectomy (LPD)</measure>
    <time_frame>90 postoperative days</time_frame>
    <description>Morbimortality of Laparoscopic pancreaticoduodenectomy (LPD) compared to the gold standard Open pancreaticoduodenectomy approach (OPD) :Overall morbidity (according to Clavien Dindo Classification)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of lymph nodes removed</measure>
    <time_frame>14 postoperative days</time_frame>
    <description>Number of lymph nodes removed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Margins of excision</measure>
    <time_frame>14 postoperative days</time_frame>
    <description>Margins of excision R0, R1, R2</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Pancreatoduodenectomy</condition>
  <arm_group>
    <arm_group_label>Patients with an open approach</arm_group_label>
    <description>Patients requiring pancreatoduodenectomy and operated with an open approach : All consecutive patients requiring pancreato-duodenectomies for benign or malignant pathology before the first laparoscopic pancreaticoduodenectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with a laparoscopic approach</arm_group_label>
    <description>Patients requiring pancreatoduodenectomy and operated with a laparoscopic approach : All consecutive patients requiring pancreato-duodenectomies for benign or malignant pathology operated with a laparoscopic approach.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pancreatoduodenectomy</intervention_name>
    <description>Open or laparoscopic pancreato-duodenectomy with pancreatojejunal anastomosis</description>
    <arm_group_label>Patients with a laparoscopic approach</arm_group_label>
    <arm_group_label>Patients with an open approach</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who had Pancreatoduodenectomy with pancreatojejunal anastomosis whatever the
        indication
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        - Pancreatoduodenectomy with pancreatojejunal anastomosis whatever the indication

        Exclusion criteria:

        -reject the study protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>REGIS SOUCHE</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 6, 2020</study_first_submitted>
  <study_first_submitted_qc>May 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2020</study_first_posted>
  <last_update_submitted>May 10, 2020</last_update_submitted>
  <last_update_submitted_qc>May 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pancreatoduodenectomy</keyword>
  <keyword>Benign or malign pathology</keyword>
  <keyword>Mini-invasive approach</keyword>
  <keyword>Morbimortality</keyword>
  <keyword>Laparoscopic approach</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

